DV
Dividend Vision

CLGN — Collplant Biotechnologies Ltd

Collplant Biotechnologies Ltd (CLGN)

Total return is -98.2% over the past 11.3 years, 439.1 points behind SPY at 340.9%. Its deepest 1-year drawdown was 91.3%.

Collplant Biotechnologies Ltd is an equity stock focused on the biotechnology sector. As a single-stock holding rather than a diversified fund, it does not operate as a traditional ETF with a defined income strategy, and currently carries no distribution rate or publicly available expense ratio data. This holding appeals primarily to investors seeking exposure to biotechnology innovation rather than those pursuing dividend income or broad market diversification.

CLGN key facts

Asset type
Stock
Asset class
Equity
Inception date
05/14/2015
Last close
$0.33
Market cap
$6,334,250
Average volume
70800.0
Payment date
11/21/2016
Beta
0.654
Payout ratio
0.0
Forward P/E
80.0
EPS
$-1.04